We are on the path for a cure, but this is only just the start.

In recent months we have seen breakthroughs in the form of Alzheimer's drugs lecanemab and donanemab. These first-generation drugs are far from the end of the story, but they are proof we are on the right track. We must keep this momentum going.

Alzheimer's Research UK will not stop until every person is free from the heartbreak of dementia.

But to achieve this, we need you to keep supporting dementia research. Your backing will get us there.

Our Director of Research, Dr Susan Kohlhaas, calls on you to join us.

Stand #ForACure 🟧

https://www.alzheimersresearchuk.org/...